SCHEMBL30333672

SCHEMBL30333672

[2H]c1cc(-c2ccc3c(N4CCNCC4)ncnc3c2)cnc1OC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 12/20 0.53
CYP3A4 P08684 12/20 0.53
CLK4 Q9HAZ1 9/20 0.53
CYP2C19 P33261 7/20 0.53
USP2 O75604 6/20 0.53
HSD17B10 Q99714 4/20 0.53
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 3/20 0.50
GAK O14976 2/20 0.50
CYP2D6 P10635 4/20 0.48
MAPT P10636 2/20 0.48
HPGD P15428 2/20 0.48
LMNA P02545 5/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.44
MAPK1 P28482 2/20 0.43
ENPP1 P22413 1/20 0.41
PIK3CD O00329 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30333558 0.92 CYP1A2 (0.64) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30334425 0.85 CYP1A2 (0.50) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333371 0.80 CYP1A2 (0.47) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333730 0.79 CYP1A2 (0.49) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30334606 0.77 CYP1A2 (0.55) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333230 0.77 CYP1A2 (0.46) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30332986 0.76 CYP1A2 (0.46) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30572735 0.72 PIK3CA (0.55) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL2921599 0.72 HTT (0.58) CYP1A2CYP3A4CLK4CYP2C19USP2
SCHEMBL30333110 0.71 MTOR (0.55) CYP1A2CYP3A4CLK4CYP2C19USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023045960-A1 PYRIDINE DERIVATIVE AND USE THEREOF 四川汇宇制药股份有限公司 2023-03-30 WO disclosed